Global Artificial Organ And Bionics Market Growth (Status and Outlook) 2023-2029

Global Artificial Organ And Bionics Market Growth (Status and Outlook) 2023-2029

An artificial organ is a device which is man-made and is integrated or implanted into the human in order to restore target function via the replacement of a natural organ. The material used to develop body interfaces or implants are known as biomaterials. Processing abilities that are not occurring naturally can be constructed and installed with the help of artificial organs and replaced function need not be in the context of life support but generally, it is to support life.

LPI (LP Information)' newest research report, the “Artificial Organ And Bionics Industry Forecast” looks at past sales and reviews total world Artificial Organ And Bionics sales in 2022, providing a comprehensive analysis by region and market sector of projected Artificial Organ And Bionics sales for 2023 through 2029. With Artificial Organ And Bionics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Organ And Bionics industry.

This Insight Report provides a comprehensive analysis of the global Artificial Organ And Bionics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artificial Organ And Bionics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Artificial Organ And Bionics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Organ And Bionics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Organ And Bionics.

The global Artificial Organ And Bionics market size is projected to grow from US$ 23770 million in 2022 to US$ 34780 million in 2029; it is expected to grow at a CAGR of 5.6% from 2023 to 2029.

North America held the largest share in the artificial organ or medical bionic implant space, followed by Europe. However, the market is emerging due to the rise in population coupled with awareness among the players and the patients. Growing income levels, increasing healthcare expenditure, less competition than mature countries are the factors which are responsible for increasing the market players’ interest in emerging markets. Asia-Pacific region is expected to rise and hold a larger share of this market in near future because of the rise in medical tourism, improvement in healthcare infrastructure and others.

This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Organ And Bionics market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Mechanical Bionics
Electronic Bionics

Segmentation by application
Hospital
Clinic

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abiomed Inc.
Asahi Kasei Kuraray Medical Co. Ltd.
Thoratec Corporation
WorldHeart Corp.
Gambro AB
Biomet Inc.
Cochlear Ltd.
Berlin Heart Gmbh
Ekso Bionics
Medtronic Inc.
Lifenet Health
Heartware International Inc.
Jarvik Heart Inc.
Walk Inc.
Ossur
Boston Scientific Corporation
Sorin S.P.A.

Please note: The report will take approximately 2 business days to prepare and deliver.